Making Sense of Next-Generation Sequencing Data
What a difference a year makes for Illumina. Unlike last year, Illumina has started this year on a strong foot; Roche chief says Illumina is not a must have, but nice to have and Illumina announces the acquisition of Verinata Health, a non-invasive prenatal testing company. The year 2012 was a busy year for many personal [...]
BGI announces that US federal govt, Committee on Foreign Investment in the United States (“CFIUS”), has cleared BGI’s acquisition of US sequencing company Complete Genomics. In September, BGI-Shenzhen, the leading Chinese company in offering sequencing services announced that it is acquiring California based Complete Genomics for about $117.6 million. In November, Illumina got in to the acquisition picture [...]
NextGenSeek’s link roundup presents interesting stories/happenings in Genomics to read this weekend. This week’s NextGenSeek stories are dominated by acquisition news in Genomics. The biggest surprising acquisition news is BGI’s acquisition of CompleteGenomics. Other interesting stories include Illumina’s Acquisition of BlueGnomics, Roche’s New Research facility at New York, and NPR’s three-part “$1000 genome” series. [Update] This [...]
This week’s Nature has a rather interesting paper showing a link between Father’s age and increase in de novo mutations and possibly disease association with autisim and schizophrenic. Kong et. al.’s study shows that on an average men can give rise to 2 de novo mutations per year. Increase in mutation rate is troublesome, as this has [...]
Complete Genomics, the Mountain View based human whole genome sequencing technology company has been in the news for both good and bad. On the bad side, Complete Genomics had to lay off its 55 employees to reduce spending. On the good side, Complete Genomics published a paper in Nature presenting Long Fragment Read (LFR) technology [...]
Complete Genomics announced that it has developed a new sequencing technology that improves the accuracy of whole genome sequencing with reduced amount of DNA. The new Complete Genomics’ technology known as Long Fragment Read (LFR) technology allows Complete Genomics to solve phasing genomes, one of the important bottlenecks of existing short read sequencing. Human genomes are [...]
Illumina announced that it is filing its second patent infringement lawsuit against Complete Genomics, Inc. The new lawsuit was filed for Complete Genomics’ infringement of U.S. Patent No. 8,192,930, titled “Method for Sequencing a Polynucleotide Template.” This time Illumina is targeting Complete Genomics’ Combinatorial Probe-Anchor Ligation (cPal) read technology. Complete Genomcis uses a library prep [...]
Complete Genomics, the Mountain View based whole genome human sequencing and analysis company, announced that it will be laying off 55 employees by 30th June. The lay off is pat of its effort to reduce spending and will be using Jefferies & Company, Inc. to explore strategic alternatives. In the press release announcing the restructuring, [...]
